Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | 5.17 | - | 5.17 | - | Molbase, MSDS |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
AUC | 8165.0 | ng.h/ml | 8165.0 | ng.h/ml | DRUGBANK | AUC | 20276.0 | ng.h/ml | 20276.0 | ng.h/ml | DRUGBANK |
C Max | 552.0 | ng/ml | 552 | ng/ml | DRUGBANK | C Max | 1452.0 | ng/ml | 1452 | ng/ml | DRUGBANK |
T Max | 2.5 | h | 1-4 | h | PO, oral; | DRUGBANK |
Metabolic | 72.4 | % | 72.4 | % | Liver metabolism; | DRUGBANK | Metabolic | 27.6 | % | 27.6 | % | Liver metabolism; | DRUGBANK |
Clearance | 12.7 | L/h | 12.7 | L/h | apparent clearance; PO, oral; at steady state; | DRUGBANK |
Volume of Distribution | 153.0 | L | 153.0 | L | Apparent volume of distribution; at steady state; | DRUGBANK |
Half-life | 25.0 | h | 25 | h | at steady state; | DRUGBANK |
Eliminate Route | 65.0 | % | 65 | % | Faeces excretion; | DRUGBANK | Eliminate Route | 25.0 | % | 25 | % | Urinary excretion; | DRUGBANK |
Protein Binding | 66.0 | % | 66 | % | plasma proteins; | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Frequency | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|---|
Max dose for adults | 180.0 | mg/day | 180 | mg/day | PO, oral | qd | Alunbrig | brigatinib | PDR |
Max dose for geriatric | 180.0 | mg/day | 180 | mg/day | PO, oral | qd | Alunbrig | brigatinib | PDR |